Evidence map›Paper›PMID 31768763›Full record

ArticleIn vitro cellular & developmental biology. Animal2020

Induction of integration-free human-induced pluripotent stem cells under serum- and feeder-free conditions.

Atsuko Hamada, Eri Akagi, Sachiko Yamasaki, Hirotaka Nakatao, Fumitaka Obayashi, Manami Ohtaka, Ken Nishimura, Mahito Nakanishi, Shigeaki Toratani, Tetsuji Okamoto

Abstract read
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Atsuko HamadaDepartment of Oral and Maxillofacial Surgery, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima-City, 734-8553, Japan.
Eri AkagiDepartment of Oral Maxillofacial Surgery, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
Sachiko YamasakiDepartment of Oral and Maxillofacial Surgery, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima-City, 734-8553, Japan.
Hirotaka NakataoDepartment of Oral and Maxillofacial Surgery, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima-City, 734-8553, Japan.
Fumitaka ObayashiDepartment of Oral and Maxillofacial Surgery, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima-City, 734-8553, Japan.
Manami OhtakaTOKIWA-Bio, Inc., Tsukuba, Ibaraki, Japan.
Ken NishimuraLaboratory of Gene Regulation, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Mahito NakanishiTOKIWA-Bio, Inc., Tsukuba, Ibaraki, Japan.
Shigeaki TorataniDepartment of Molecular Oral Medicine and Maxillofacial Surgery, Division of Applied Life Science, Graduate Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
Tetsuji OkamotoDepartment of Oral and Maxillofacial Surgery, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima-City, 734-8553, Japan. tetsuok@hiroshima-u.ac.jp.ORCID http://orcid.org/0000-0001-7392-5547

Funding

Japanese Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Research Activity Start-up 15H06435Japanese Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Young Scientists (B) 16K20580Japanese Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research (B) 18H03000
6 · The paper itself

Abstract

Human-induced pluripotent stem cells (hiPSCs) have shown great potential toward practical and scientific applications. We previously reported the generation of human dental pulp stem cells using non-integrating replication-defective Sendai virus (SeVdp) vector in feeder-free culture with serum-free medium hESF9. This study describes the generation of hiPSCs from peripheral blood mononuclear cells to increase the donor population, while reducing biopsy invasiveness. From 6-d-old primary culture of peripheral blood mononuclear cells (PBMCs) with IL-2, hiPSCs were established using SeVdp(KOSM)302L with recombinant Laminin-511 E8 fragments under serum-free condition. The established PBMC-derived hiPSCs showed pluripotency and differentiation ability both in vivo and in vitro. In addition, we evaluated microarray data from PBMC- and dental pulp-derived hiPSCs. These hiPSCs will be beneficial for characterizing the molecular mechanisms of cellular differentiation and may provide useful substrates for developing cellular therapeutics.

Indexed as

Alkaline PhosphataseCell LineCellular ReprogrammingCulture Media, Serum-FreeFeeder CellsHumansInduced Pluripotent Stem CellsLeukocytes, MononuclearAlkaline PhosphataseCulture Media, Serum-FreehESF9 serum-free defined mediaHuman-induced pluripotent stem cellsPeripheral blood mononuclear cellsReprogramming efficiency

Identifiers

PMID31768763
PMCPMC6989583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.